Project Grant R21HD113794
Award Date
9/10/24
Completion Date
8/31/26
Dollars Obligated
$426K
Federal Agency
National Institute of Child Health and Human Development
Federal Grant Program
93.865
Assistance Type
Project Grant
Place of Performance
Rochester, MI, USA
Similar Awards
This federal Project Grant award of $205,048.00, awarded by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research), will support research to optimize dimensions of reinforcement to enhance behavioral interventions for individuals with intellectual and developmental disabilities (IDD) who engage in severe problem behaviors. The primary grantee, Auburn University, will lead the research project using a...
This federal Project Grant award R21HD112724, provided by the National Institute of Child Health and Human Development (CFDA 93.865 Child Health and Human Development Extramural Research), supports a single-arm pilot trial to evaluate tactics for mitigating relapse of severe problem behavior (SPB) in individuals with intellectual and developmental disabilities (IDD). The $213,209 award, with a project period from Sep 1, 2024 to Aug 31, 2026, will be used to assess the feasibility and preliminary...
This Project Grant award from the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $431,750 to a collaborative research partnership between Henry Ford Health and Michigan State University Health Sciences. The funding will support a 2-year investigation into the neurobiological mechanisms underlying heterogeneity in social behavior development among young...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $2,075,613 research project conducted by the Regents of the University of Michigan. The project aims to validate a human sign-/goal-tracking paradigm and identify neurobehavioral signatures of sign- and goal-tracking behaviors in emerging adults, which are key to understanding individual differences in addiction liability. The...
This $2,419,326 Project Grant awarded by the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), supports a longitudinal study to investigate neurobehavioral and psychosocial predictors of health risk behaviors (HRBs) in adolescence and young adulthood. The primary awardee, Virginia Polytechnic Institute & State University, will conduct assessments over 15 years to understand brain development and its impact on substance use and...
This federal Project Grant award of $242,290, provided by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to develop a measure to assess the fidelity of neurodiversity-affirming interventions (NAIs) for autistic individuals. The goal is to leverage qualitative interviews with autistic individuals and caregivers to establish a pool of items indicating the...
This Project Grant award from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) provides $389,880 to the University of North Carolina at Chapel Hill to develop and test behavioral economics and financial incentive-based strategies to improve treatment engagement, medication adherence, and substance avoidance for patients transitioning from first-episode psychosis coordinated specialty care to post-care. The 5-year award, beginning...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), is funding research to investigate the role of the glucocorticoid receptor (GR) as a neuromolecular mechanism regulating impulsivity within the prelimbic cortex-nucleus accumbens pathway. The total award amount is $127,635, with a project period from June 17, 2025 to December 31, 2025. The research, conducted by the Regents of the University of Michigan,...
This Project Grant award from the National Institute on Drug Abuse (NIDA), under the federal Drug Use and Addiction Research Programs (CFDA 93.279), will support a $346,911 cross-species research study to identify early life environmental and genetic risk factors for substance use disorders (SUDs). The key objectives are to: 1) determine how early life environment influences neurocognitive development and its relationship to adult impulsivity behaviors; 2) identify genomic networks associated...
This $3,226,170 Project Grant award from the National Institute on Drug Abuse (CFDA 93.279 - Drug Use and Addiction Research Programs) will support a randomized clinical trial to evaluate the effectiveness of cognitive skills training interventions in improving outcomes for offenders with substance use disorders. The award recipient, Lovelace Biomedical Research Institute, will conduct the study to demonstrate the reliability and generalizability of their prior pilot findings, which showed...